Skip to main content
. 2020 Jul 14;12(7):1895. doi: 10.3390/cancers12071895

Figure 3.

Figure 3

(A) Survival curves after 8 administrations of Dex 5%, free gemcitabine (Gem), squalenoyl–gemcitabine/edelfosine nanoassemblies (SQ–Gem/EF NAs) or SQ–Gem NAs at 38 μmol/kg (Eq. to EF, SQ–Gem and Gem) in tumor-bearing mice; (B) body-weight change over time (days). Values are means ± SD (n = 7), * p < 0.05.